Mode
Text Size
Log in / Sign up
N/A Completed N=512 Randomized Screening

The INSPIRE-Lung Study

Source: ClinicalTrials.gov NCT05824273 ↗
Enrolled (actual)
512
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcomePrimary: Reaching Screening Eligible Individuals Via Social Media - Reach — 1048191 participants

Summary

LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals nationwide.

Outcome Measures

OutcomeResultp-value
PRIMARY
Reaching Screening Eligible Individuals Via Social Media - Reach
1048191
PRIMARY
Reaching Screening Eligible Individuals Via Social Media - Link Clicks
24816
PRIMARY
Reaching Screening Eligible Individuals Via Social Media - Impressions
3109482
PRIMARY
Effectiveness of LungTalk - Knowledge Assessment
6; 6
PRIMARY
Effectiveness of LungTalk - Perceived Risk
7; 7
PRIMARY
Effectiveness of LungTalk - Perceived Benefits
20.5; 21
PRIMARY
Effectiveness of LungTalk - Perceived Barriers
25; 25
PRIMARY
Effectiveness of LungTalk - Self-Efficacy
33; 33
PRIMARY
Effectiveness of LungTalk - Occurrence of a Patient-Clinician Discussion
193; 161
PRIMARY
Effectiveness of LungTalk - Screening Uptake
134; 125

Eligibility Criteria

Inclusion Criteria

  • ≥20-pack-year smoking history;
  • Individuals who currently smoke or quit smoking within the past 15 years

Exclusion Criteria

  • Previously undergone LDCT for early detection of lung cancer, have a lung nodule or nodules that are currently being followed
  • Has ever been diagnosed with lung cancer
  • Individuals with impaired decision-making (because our primary outcome is decision-making, we will not include individuals with impaired decision-making)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05824273). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search